A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: Clinical and dosimetric factors analysis

Radiotherapy and Oncology

Volumn 71, Issue 2, 2004, Pages 175-181

  Claude, Line ^a   Pérol, David ^a   Ginestet, Chantal ^a   Falchero, Lionel ^b   Arpin, Dominique ^c   Vincent, Michel ^d   Martel, Isabelle ^a   Hominal, Stéphane ^e   Cordier, Jean François ^f   Carrie, Christian ^a  

^a CENTRE LÉON BÉRARD   (France)

^b CENTRE HOSPITALIER   (France)

^c Hopital des Chanaux   (France)

^d CENTRE HOSPITALIER SAINT JOSEPH SAINT LUC   (France)

^e CROIX ROUSSE HOSPITAL   (France)

^f LOUIS PRADEL HOSPITAL   (France)

Author keywords

Conformal radiation therapy; Dose volume histogram; Non small cell lung cancer; Radiation pneumonitis

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG DISEASE; LUNG NON SMALL CELL CANCER; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION PNEUMONIA; THREE DIMENSIONAL IMAGING; TIME SERIES ANALYSIS;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FRANCE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 11144354573     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2004.02.005     Document Type: Article

References (22)

1. Armstrong J., Raben A., Zelefsky M., et al. Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. Radiother Oncol. 44:1997;17-22.
2. Byhardt R.W., Martin L., Pajak T.F., Shin K.H., Emami B., Cox J.D. The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC) - analysis of a radiation therapy oncology group (RTOG) protocol. Int J Radiat Oncol Biol Phys. 27:1993;537-544.
3. Cox D.J., Azarnia N., Byhardt R.W., Shin K.H., Emami B., Pajak T.F. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60 Gy to 79.2 Gy: possible survival benefit with >69.6 Gy in favorable patients with radiation Therapy Oncology Group Stage III Non-Small-Cell lung Carcinoma: report of Radiation of Radiation Therapy Oncology Group 83-11. J Clin Oncol. 8:1990;1543-1555.
4. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
5. Gagliardi G., Bjohle J., Lax I., et al. Radiation pneumonitis after breast cancer irradiation: analysis of the complication probability using the relative seriality model. Int J Radiat Oncol Biol Phys. 46:2000;373-381.
6. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 45:1999;323-329.
7. Hernando M.L., Marks L.B., Bentel G.C., et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys. 51:2001;650-659.
8. Hilsenbeck S.G., Clark G.M., Mc Guire W.L. Why do so many prognostic factors fail to pan out? Breast Cancer Res Treat. 22:1992;197-206.
9. ICRU-50. Prescribing, recording, reporting, photon beam therapy. 1994;International Commission on Radiation Units and Measurements, Washington, DC.
10. Koga K., Kusumoto S., Watanabe K., Nishikawa K., Harada K., Ebihara H. Age factor relevant to the development of radiation pneumonitis in radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys. 14:1988;367-371.
11. Kwa S.L.S., Lebesque J.V., Theuws J.C.M., et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys. 42:1998;1-9.
12. Lebesque J.V., Seppenwoolde Y., Belderbos J.S., et al. Radiation pneumonitis and NTCP models. Int J Radiat Oncol Biol Phys. 51:(Suppl 1):2001;. abstr. 154:86.
13. Lee J.S., Scott C., Komaki R., et al. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06. J Clin Oncol. 14:1996;1055-1064.
14. LENT SOMA Tables. Radiother Oncol. 35:1995;17-60.
15. Martel M., Graham M. Dose volume histograms (DVHs) and normal tissue complication probabilities (NTCPs) and their clinical applications. Treatment optimisation for lung cancer: from classical to innovative procedures. 1998;Elsevier, Paris. p. 125-38.
16. Martel M.K., Ten Haken R.K., Hazuka M.B., Turrisi A.T., Fraass B.A., Lichter A.S. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys. 28:1994;575-581.
17. Monson J.M., Stark P., Reily J.J., et al. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer. 82:1998;842-850.
18. Perez C.A., Stanley K., Grundy G., et al. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non oat cell carcinoma of the lung: report by the RTOG. Cancer. 50:1982;1091-1099.
19. Roach M. III, Gandara D.R., You H.S., et al. Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J Clin Oncol. 13:1995;2606-2612.
20. Robnett T.J., Machtay M., Vines E.F., McKenna M.G., Algazy K.M., McKenna W.G. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys. 48:2000;89-94.
21. Sunyach M.P., Falchero L., Pommier P., et al. Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell-lung cancer: preliminary results. Int J Radiat Oncol Biol Phys. 48:2000;459-463.
22. Yamada M., Kudoh S., Hirata K., Nakajima T., Yoshikawa J. Risk factors of pneumonitis following chemoradiotherapy for lung cancer. Eur J Cancer. 34:1998;71-75.